In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Cerner, Duke to Pilot Cerner Learning Network to Innovate Clinical Research Registries
Cerner Corporation has announced the development of the Cerner Learning Health Network to help clinicians more easily and efficiently gain health insights and guide care. As part of the development, Cerner and the Duke Clinical Research Institute (DCRI) have joined together to pilot the Cerner Learning Health Network and innovate clinical research registries in the process.Learning Registry by the DCRI Pilot ProjectThe pilot project and study, named the Learning Registry by the DCRI, will use
Read More
Backed by Mayo Clinic Study, Eko Launches Cardiac Remote Monitoring App, Eko Home
Currently being used in a study by Mayo Clinic, cardiac monitoring app Eko Home enhances outpatient cardiac data collection and demonstrates real world efficacyEko, a Silicon Valley-based digital health company applying machine learning in the fight against heart disease, today announced its cardiac remote monitoring app, Eko Home. The app is a first-of-its-kind service that enables precise remote monitoring of cardiac function using ECG and heart sounds. Eko Home can be used to create drug-data
Read More
Sharecare Names Quest Diagnostic As Lab Partner For Its Digital Health Platform
Sharecare has named Quest Diagnostics its preferred laboratory partner for its comprehensive digital health platform. Sharecare and Quest Diagnostics also intend to jointly explore the development of disease management programs and other services to empower better health. In addition, Quest has made a strategic investment in Sharecare for an undisclosed sum with Goldman Sachs serving as Sharecare's financial advisor. Financial terms of the strategic investment were not disclosed.Sharecare
Read More
Eko Unveils Investigational Aortic Stenosis (AS) Detection Algorithm
Eko, a Berkeley-based digital health company applying artificial intelligence and machine learning in the fight against heart disease unveiled an investigational Aortic Stenosis (AS) detection algorithm at the American Society of Echocardiography (ASE) 2019 Scientific Sessions aimed to assist healthcare providers in the early detection of clinically significant AS. The algorithm represents a major step forward toward Eko’s mission to empower healthcare providers with tools to more accurately
Read More
Blue Shield of California Launches Digital Therapeutics Platform At No Cost to Members
Blue Shield of California is launching a new digital therapeutics platform that will provide programs to eligible members at no cost to them. Powered by Solera Health, the new Wellvolution platform provides curated, scientific and results-based digital programs that can be personalized to each of its members' individual health needs and preferences. The program is available at no cost to members enrolled in Blue Shield's fully insured employer-sponsored plans or it's Individual and Family
Read More
Cara Care Nabs $7M to Expand Digital Therapuetic App for Digestive Diseases
Berlin, Germany-based digital health company Cara Care, announced today that it has secured $7 million in Series A funding led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Barcelona-based VC firm Asabys Partners with participation from existing investor Atlantic Labs. Cara Care was part of the Microsoft Accelerator and winner of the GlaxoSmithKline Transforming the Future of Self-Care Challenge in the category “Digital Health Technologies.” Cara Care has raised more than $9
Read More
NightWare Awarded FDA “Breakthrough Status” for PTSD Apple Watch App
NightWare, Inc., digital therapeutics for mental health company has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA) for its NightWare Apple Watch app that measures and treats nightmares in people with Post-Traumatic Stress Disorder (PTSD).Impact of Nightmare DisordersNightmares and Nightmare Disorder have been linked to increased suicidality, heightened risk of heart disease, diabetes, and contributes to cognitive difficulties such as memory loss,
Read More
Verily Launches Baseline Health System Consortium with Duke, Mayo, Vanderbilt
Verily, an Alphabet company, today announced a new Project Baseline initiative, the Baseline Health System Consortium, comprised of Verily, Duke University Health System, Vanderbilt University Medical Center, University of Mississippi Medical Center, Mayo Clinic, Regional Health in South Dakota and the University of Pittsburgh. Verily launched Project Baseline in 2017 with the Project Baseline Health Study to develop the technology and tools to help researchers create a more comprehensive map of
Read More
5 Groundbreaking Findings from the Stanford and Apple Heart Study
Stanford Medicine researchers recently released preliminary results of the Apple Heart Study, the largest study ever of its kind, which enrolled over 400,000 participants from all 50 states in a span of only eight months.
Apple Heart Study Overview
Presented at American College of Cardiology’s 68th Annual Scientific Session and Expo in New Orleans, the study was launched in 2017 to evaluate Apple Watch’s irregular rhythm notification, which occasionally checks the heart's rhythm in the
Read More
